A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung.

Background In a previous phase 3 trial of adjuvant chemotherapy after resection of non-small-cell lung cancer, a combination of uracil and tegafur (often referred to as UFT) taken orally was shown to prolong survival. A subgroup analysis disclosed that most patients who benefited had pathological st... View More